Jesús M Paramio

26PUBLICATIONS
82CO-AUTHORS
Molecular targetsPredictive and prognostic markersCancer diagnosisCancer therapy (excl. chemotherapy and radiation therapy)Chemotherapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (26)

|Oct 16, 2026
CABOPRE: Evaluating Perioperative Cabozantinib's Efficacy and Biomarkers for Cytoreductive Nephrectomy in Advanced Renal Cell Carcinoma.

|Feb 22, 2026
Cell-of-origin and genetic drivers define advanced bladder cancer subtypes and potential therapeutic response in mouse models.

Ester Munera-Maravilla, Mercedes Pérez-Escavy, Carolina Rubio

|Dec 19, 2024
Characterisation of the tumour microenvironment and PD-L1 granularity reveals the prognostic value of cancer-associated myofibroblasts in non-invasive bladder cancer.

Carmen G Cañizo, Félix Guerrero-Ramos, Mercedes Perez Escavy

|Nov 07, 2024
Nuclear versus cytoplasmic IKKα signaling in keratinocytes leads to opposite skin phenotypes and inflammatory responses, and a different predisposition to cancer.

Verónica A García-García, Josefa P Alameda, M Jesús Fernández-Aceñero

|Jan 03, 2024
Modulation of tumor microenvironment by targeting histone acetylation in bladder cancer.

Sandra P Nunes, Lucia Morales, Carolina Rubio

|Aug 12, 2022
Pten and p53 Loss in the Mouse Lung Causes Adenocarcinoma and Sarcomatoid Carcinoma.

Sara Lázaro, Corina Lorz, Ana Belén Enguita

Pageof 5

Frequent Collaborators

6 joint publications

Iris Lodewijk

5 joint publications

Alejandra Bernardini

5 joint publications

Marta Dueñas

4 joint publications

Cristian Suárez-Cabrera